Log in to save to my catalogue

GLP-1 Receptor Agonists in Neurodegeneration: Neurovascular Unit in the Spotlight

GLP-1 Receptor Agonists in Neurodegeneration: Neurovascular Unit in the Spotlight

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_bfb7e6b2839e4e16a0d1fa9c6ebba0d4

GLP-1 Receptor Agonists in Neurodegeneration: Neurovascular Unit in the Spotlight

About this item

Full title

GLP-1 Receptor Agonists in Neurodegeneration: Neurovascular Unit in the Spotlight

Publisher

Basel: MDPI AG

Journal title

Cells (Basel, Switzerland), 2022-06, Vol.11 (13), p.2023

Language

English

Formats

Publication information

Publisher

Basel: MDPI AG

More information

Scope and Contents

Contents

Defects in brain energy metabolism and proteopathic stress are implicated in age-related degenerative neuronopathies, exemplified by Alzheimer’s disease (AD) and Parkinson’s disease (PD). As the currently available drug regimens largely aim to mitigate cognitive decline and/or motor symptoms, there is a dire need for mechanism-based therapies that...

Alternative Titles

Full title

GLP-1 Receptor Agonists in Neurodegeneration: Neurovascular Unit in the Spotlight

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_bfb7e6b2839e4e16a0d1fa9c6ebba0d4

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_bfb7e6b2839e4e16a0d1fa9c6ebba0d4

Other Identifiers

ISSN

2073-4409

E-ISSN

2073-4409

DOI

10.3390/cells11132023

How to access this item